Abstract: Objective To observe the changes of model for end-stage liver disease (MELD) scores and
proprocalcitonin(PCT) of patients with acute-on-chronic liver failure(ACLF), and to evaluate the predictive
value of MELD combined with PCT on the short-term prognosis in patients with ACLF. Methods Total
of 83 patients with ACLF in the First Affiliated Hospital of Guangxi University of Chinese Medicine
and Tiandong Chinese Medicine Hospital from June 2012 to March 2015 were selected and divided
into survival group (43 cases) and death group (40 cases), the changes of biochemical indexes, MELD
score and PCT in the two groups were compared. Results ①Total of 40 patients died in all 83 patients with
ACLF at the end of the 12 weeks, the total mortality rate was 49.43%. ②There were no significant differences
of all indexes between two groups before treatment (t = 0.594, 0.644, 0.215, 1.326, 0.053; P = 0.554, 0.522,
0.830, 0.188, 0.958). The difference in TBil and INR had no statistical significance (t = 0.994, 1.160; P =
0.324, 0.250), but the difference in Cr, PCT and MELD scores had statistical significance (t = 0.745, P =
0.000) between survival group and death group after two weeks. The differences of TBil, Cr, INR, PCT and
MELD scores were statistically significant between the two groups after 4 weeks (t = 5.346, 3.951, 3.571,
15.995, 8.085; P = 0.000). ③The AUC of MELD score combined with PCT was 0.751, which was higher than 0.722 only by MELD score and 0.684 by PCT within 12 weeks for patients with ACLF. Conclusion MELD
score combined with PCT has a good predictive value on the short-term prognosis in patients with ACLF.
|